netter 1 phase iii in patients with midgut neuroendocrine tumors treated with 177lu dotatate efficac
Published 7 years ago • 880 plays • Length 23:34Download video MP4
Download video MP3
Similar videos
-
1:59
netter-1 update: 177lu-dotatate in patients with midgut neuroendocrine tumors
-
1:19
dr. strosberg on future of 177lu-dotatate therapy in neuroendocrine tumors
-
2:58
netter-1: radioactive octreotide effective in metastatic neuroendocrine tumors
-
2:16
dr. strosberg on quality of life findings for lu-dotatate in patients with midgut nets
-
5:00
netter-1: phase iii efficacy and safety results in patients...
-
2:03
dr. strosberg on the results of the netter-1 trial
-
1:25
dr. jonathan r. strosberg on the netter-1 trial and its impact on patients with midgut nets
-
5:52
netter-1 clinical trial overview
-
1:36
dr. strosberg on netter-1 trial results for midgut nets
-
2:16
dr. strosberg on quality of life for midgut neuroendocrine tumors
-
3:09
new treatment for neuroendocrine tumors
-
8:03
ecc 2015: netter-1 trial showed rare cancer responded unusually well to new treatment
-
6:10
treatments for neuroendocrine tumors
-
6:11
understanding your neuroendocrine cancer diagnosis
-
5:38
symptoms types and diagnosis of neuroendocrine tumours (nets)
-
18:58
treatment update on neuroendocrine cancers
-
13:35
abcs of neuroendocrine cancer: 2020 update
-
34:45
day2 ksnmmi 2013 - 19 lu 177 therapy in neuroendocrine tumor
-
5:24
neuroendocrine tumor guidelines